ReviewCells2023

NLRP3 Inflammasome as a Potentially New Therapeutic Target of Mesenchymal Stem Cells and Their Exosomes in the Treatment of Inflammatory Eye Diseases.

Carl Randall Harrell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.